These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32591170)

  • 41. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study.
    Greer TL; Grannemann BD; Chansard M; Karim AI; Trivedi MH
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):248-56. PubMed ID: 25453481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia.
    Tan S; Zhu X; Fan H; Tan Y; Yang F; Wang Z; Zhao Y; Fan F; Guo J; Li Z; Quan W; Wang X; Reeder C; Zhou D; Zou Y; Wykes T
    Psychol Med; 2020 Jul; 50(10):1633-1643. PubMed ID: 31298171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.
    van Balkom TD; Berendse HW; van der Werf YD; Twisk JWR; Zijlstra I; Hagen RH; Berk T; Vriend C; van den Heuvel OA
    BMC Neurol; 2019 Jul; 19(1):179. PubMed ID: 31366395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
    Vieta E; Sluth LB; Olsen CK
    J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot study.
    Hahn B; Shrieves ME; Yuille MB; Buchanan RW; Wells AK
    Psychiatry Res; 2019 Oct; 280():112498. PubMed ID: 31437659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive control therapy and transcranial direct current stimulation for depression: a randomized, double-blinded, controlled trial.
    Brunoni AR; Boggio PS; De Raedt R; Benseñor IM; Lotufo PA; Namur V; Valiengo LC; Vanderhasselt MA
    J Affect Disord; 2014 Jun; 162():43-9. PubMed ID: 24767004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention - study protocol.
    Van de Velde N; Kappen M; Koster EHW; Hoorelbeke K; Tandt H; Verslype P; Baeken C; De Raedt R; Lemmens G; Vanderhasselt MA
    BMC Psychiatry; 2020 Sep; 20(1):453. PubMed ID: 32938410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Donohoe G; Dillon R; Hargreaves A; Mothersill O; Castorina M; Furey E; Fagan AJ; Meaney JF; Fitzmaurice B; Hallahan B; McDonald C; Wykes T; Corvin A; Robertson IH
    Psychol Med; 2018 Apr; 48(5):751-764. PubMed ID: 28933314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial.
    Bryce SD; Rossell SL; Lee SJ; Lawrence RJ; Tan EJ; Carruthers SP; Ponsford JL
    J Int Neuropsychol Soc; 2018 Jul; 24(6):549-562. PubMed ID: 29352823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
    Messinis L; Nasios G; Kosmidis MH; Zampakis P; Malefaki S; Ntoskou K; Nousia A; Bakirtzis C; Grigoriadis N; Gourzis P; Papathanasopoulos P
    Behav Neurol; 2017; 2017():5919841. PubMed ID: 29463950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site, randomized controlled trial.
    Peckham SB; Ionson E; Nassim M; Ojha K; Palaniyappan L; Gati J; Thebérge J; Lazosky A; Speechley M; Barušs I; Rej S; Vasudev A
    Trials; 2019 Oct; 20(1):605. PubMed ID: 31651355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trial implementation of CIRCuiTS cognitive remediation therapy for people with schizophrenia in Orange, New South Wales.
    Thomas M; Rusten K
    Aust J Rural Health; 2019 Oct; 27(5):463-468. PubMed ID: 31663213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Online Social Cognition Training in Schizophrenia: A Double-Blind, Randomized, Controlled Multi-Site Clinical Trial.
    Nahum M; Lee H; Fisher M; Green MF; Hooker CI; Ventura J; Jordan JT; Rose A; Kim SJ; Haut KM; Merzenich MM; Vinogradov S
    Schizophr Bull; 2021 Jan; 47(1):108-117. PubMed ID: 32614046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology.
    Lin Y; Li B; Tang H; Xu Q; Wu Y; Cheng Q; Li C; Xiao S; Shen L; Tang W; Yu H; He N; Lin H; Yan F; Cao W; Yang S; Liu Y; Zhao W; Lu D; Jiao B; Xiao X; Zhou L; Chen S
    BMC Neurol; 2018 Jul; 18(1):103. PubMed ID: 30041656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.
    Smith J; Browning M; Conen S; Smallman R; Buchbjerg J; Larsen KG; Olsen CK; Christensen SR; Dawson GR; Deakin JF; Hawkins P; Morris R; Goodwin G; Harmer CJ
    Mol Psychiatry; 2018 May; 23(5):1127-1133. PubMed ID: 28533517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive remediation for depressed inpatients: Results of a pilot randomized controlled trial.
    Trapp W; Engel S; Hajak G; Lautenbacher S; Gallhofer B
    Aust N Z J Psychiatry; 2016 Jan; 50(1):46-55. PubMed ID: 26706860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression.
    Rajji TK; Bowie CR; Herrmann N; Pollock BG; Bikson M; Blumberger DM; Butters MA; Daskalakis ZJ; Fischer CE; Flint AJ; Golas AC; Graff-Guerrero A; Kumar S; Lourenco L; Mah L; Ovaysikia S; Thorpe KE; Voineskos AN; Mulsant BH;
    J Alzheimers Dis; 2020; 76(2):733-751. PubMed ID: 32568198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.